{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:10:00Z","timestamp":1792030200036,"version":"4.4.0"},"reference-count":146,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.mce.2011.05.044","type":"journal-article","created":{"date-parts":[[2011,6,13]],"date-time":"2011-06-13T00:33:00Z","timestamp":1307925180000},"page":"223-231","source":"Crossref","is-referenced-by-count":148,"title":["The role of progesterone signaling in the pathogenesis of uterine leiomyoma"],"prefix":"10.1016","volume":"358","author":[{"given":"J. Julie","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth C.","family":"Sefton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2011.05.044_b0100","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1471-0528.1988.tb12807.x","article-title":"Patterns of growth of uterine leiomyomas during pregnancy. A prospective longitudinal study","volume":"95","author":"Aharoni","year":"1988","journal-title":"Br. J. Obstet. Gynecol."},{"key":"10.1016\/j.mce.2011.05.044_b0070","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1055\/s-0030-1251481","article-title":"Magnetic resonance-guided focused ultrasound surgery","volume":"28","author":"Al Hilli","year":"2010","journal-title":"Semin. Reprod. Med."},{"key":"10.1016\/j.mce.2011.05.044_b0530","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1067\/mob.2003.118","article-title":"Expression, menstrual cycle-dependent activation, and bimodal mitogenic effect of transforming growth factor-beta1 in human myometrium and leiomyoma","volume":"188","author":"Arici","year":"2003","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.mce.2011.05.044_b0470","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1210\/er.2006-0045","article-title":"Crosstalk between the estrogen receptor and the HER tyrosine kinase receptor family: molecular mechanism and clinical implications for endocrine therapy resistance","volume":"29","author":"Arpino","year":"2008","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.mce.2011.05.044_b0170","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1479-828X.2008.00931.x","article-title":"Low-dose mifepristone in treatment of uterine leiomyoma: a randomised double-blind placebo-controlled clinical trial","volume":"49","author":"Bagaria","year":"2009","journal-title":"Aust. N Z J Obstet. Gynecol."},{"key":"10.1016\/j.mce.2011.05.044_b0300","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/humrep\/deg022","article-title":"Effect of long-term treatment with low-dose mifepristone on the endometrium","volume":"18","author":"Baird","year":"2003","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.mce.2011.05.044_b0410","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jsbmb.2006.09.030","article-title":"Progesterone signaling in breast and endometrium","volume":"102","author":"Ballare","year":"2006","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2011.05.044_b0390","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/1097-4652(2000)9999:999<000::AID-JCP1040>3.0.CO;2-E","article-title":"17-beta estradiol elicits an autocrine leiomyoma cell proliferation: evidence for a stimulation of protein kinase-dependent pathway","volume":"186","author":"Barbarisi","year":"2001","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.mce.2011.05.044_b0460","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/molehr\/gah002","article-title":"Molecular mechanisms involved in GnRH analogue-related apoptosis for uterine leiomyomas","volume":"10","author":"Bifulco","year":"2004","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.mce.2011.05.044_b0595","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/mrd.1080270203","article-title":"Expression of the insulin-like and platelet-derived growth factor genes in human uterine tissues","volume":"27","author":"Boehm","year":"1990","journal-title":"Mol. Reprod. Dev."},{"key":"10.1016\/j.mce.2011.05.044_b0405","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1097-2765(01)00304-5","article-title":"Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases","volume":"8","author":"Boonyaratanakornkit","year":"2001","journal-title":"Mol. Cell."},{"key":"10.1016\/j.mce.2011.05.044_b0715","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1095\/biolreprod63.5.1322","article-title":"Altered hormonal responsiveness of proliferation and apoptosis during myometrial maturation and the development of uterine leiomyomas in the rat","volume":"63","author":"Burroughs","year":"2000","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.mce.2011.05.044_b0305","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1093\/oxfordjournals.humrep.a019151","article-title":"Effects of daily low dose mifepristone on endometrial maturation and proliferation","volume":"11","author":"Cameron","year":"1996","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.mce.2011.05.044_b0415","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1210\/me.2006-0304","article-title":"Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways","volume":"21","author":"Carnevale","year":"2007","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2011.05.044_b0125","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1210\/jc.76.5.1217","article-title":"An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial","volume":"76","author":"Carr","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2011.05.044_b0080","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0015-0282(02)03366-6","article-title":"Coordinated regulation of HOX gene expression in myometrium and uterine leiomyoma","volume":"78","author":"Cermik","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.mce.2011.05.044_b0625","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1210\/jc.84.11.4138","article-title":"Regulation of transforming growth factor-beta1 expression by granulocyte macrophage-colony-stimulating factor in leiomyoma and myometrial smooth muscle cells","volume":"84","author":"Chegini","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2011.05.044_b0490","doi-asserted-by":"crossref","unstructured":"Chegini, N., 2010. Proinflammatory and profibrotic mediators: principal effectors of leiomyoma development as a fibrotic disorder. Semin. Reprod. Med. 28, 180\u2013203.","DOI":"10.1055\/s-0030-1251476"},{"key":"10.1016\/j.mce.2011.05.044_b0225","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1210\/jc.2005-2379","article-title":"A novel selective progesterone receptor modulator asoprisnil (J867) inhibits proliferation and induces apoptosis in cultured human uterine leiomyoma cells in the absence of comparable effects on myometrial cells","volume":"91","author":"Chen","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2011.05.044_b0030","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0029-7844(99)00305-1","article-title":"Diet and uterine myomas","volume":"94","author":"Chiaffarino","year":"1999","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.mce.2011.05.044_b0215","doi-asserted-by":"crossref","unstructured":"Chwalisz, K., Larsen, L., Mattia-Goldberg, C., Edmonds, A., Elger, W., Winkel, C.A., 2007. A randomized, controlled trial of asoprisnil, a novel selective progesterone receptor modulator, in women with uterine leiomyomata. Fertil Steril.","DOI":"10.1016\/j.fertnstert.2006.11.094"},{"key":"10.1016\/j.mce.2011.05.044_b0500","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1210\/jc.2010-0501","article-title":"Activin-a and myostatin response and steroid regulation in human myometrium: disruption of their signalling in uterine fibroid","volume":"96","author":"Ciarmela","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2011.05.044_b0720","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/1933719106298401","article-title":"Identification of a sensitive period for developmental programming that increases risk for uterine leiomyoma in Eker rats","volume":"14","author":"Cook","year":"2007","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.mce.2011.05.044_b0005","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/ajcp\/94.4.435","article-title":"The frequency of uterine leiomyomas","volume":"94","author":"Cramer","year":"1990","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.mce.2011.05.044_b0630","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jsgi.2006.02.008","article-title":"Preoperative treatment of uterine leiomyomas: clinical findings and expression of transforming growth factor-beta3 and connective tissue growth factor","volume":"13","author":"De Falco","year":"2006","journal-title":"J. Soc. Gynecol. Investig."},{"key":"10.1016\/j.mce.2011.05.044_b0480","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1093\/humrep\/den087","article-title":"A low concentration of genistein induces estrogen receptor-alpha and insulin-like growth factor-I receptor interactions and proliferation in uterine leiomyoma cells","volume":"23","author":"Di","year":"2008","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.mce.2011.05.044_b0615","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1210\/jc.81.9.3222","article-title":"Suppression of transforming growth factor-beta (TGF beta) and TGF beta receptor messenger ribonucleic acid and protein expression in leiomyomata in women receiving gonadotropin-releasing hormone agonist therapy","volume":"81","author":"Dou","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2011.05.044_b0065","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1056\/NEJMoa062003","article-title":"Uterine-artery embolization versus surgery for symptomatic uterine fibroids","volume":"356","author":"Edwards","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mce.2011.05.044_b0175","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0029-7844(02)02511-5","article-title":"Low-dose mifepristone for uterine leiomyomata","volume":"101","author":"Eisinger","year":"2003","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.mce.2011.05.044_b0210","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jmig.2005.01.022","article-title":"Twelve-month safety and efficacy of low-dose mifepristone for uterine myomas","volume":"12","author":"Eisinger","year":"2005","journal-title":"J. Minim. Invasive Gynecol."},{"key":"10.1016\/j.mce.2011.05.044_b0180","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1093\/humrep\/dep100","article-title":"Mifepristone for treatment of uterine leiomyoma. A prospective randomized placebo controlled trial","volume":"24","author":"Engman","year":"2009","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.mce.2011.05.044_b0185","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijgo.2009.11.019","article-title":"Improved quality of life is partly explained by fewer symptoms after treatment of fibroids with mifepristone","volume":"109","author":"Feng","year":"2010","journal-title":"Int. J. Gynecol. Obstet."},{"key":"10.1016\/j.mce.2011.05.044_b0190","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1097\/01.AOG.0000243776.23391.7b","article-title":"Effect of mifepristone for symptomatic leiomyomata on quality of life and uterine size: a randomized controlled trial","volume":"108","author":"Fiscella","year":"2006","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.mce.2011.05.044_b0010","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.ajog.2006.02.020","article-title":"Health care resource use for uterine fibroid tumors in the United States","volume":"195","author":"Flynn","year":"2006","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.mce.2011.05.044_b0140","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0010-7824(99)00061-X","article-title":"Effect of the levonorgestrel-releasing intrauterine system on uterine myomas in a renal transplant patient","volume":"60","author":"Fong","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.mce.2011.05.044_b0060","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1055\/s-0030-1251480","article-title":"Uterine artery embolization for fibroids: a review of current outcomes","volume":"28","author":"Freed","year":"2010","journal-title":"Semin. Reprod. Med."},{"key":"10.1016\/j.mce.2011.05.044_b0135","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1210\/jc.76.6.1439","article-title":"A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin \u201cadd-back\u201d regimens for women with leiomyomata uteri","volume":"76","author":"Friedman","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2011.05.044_b0130","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1093\/oxfordjournals.humrep.a138762","article-title":"Long-term medical therapy for leiomyomata uteri: a prospective, randomized study of leuprolide acetate depot plus either oestrogen-progestin or progestin \u2018add-back\u2019 for 2 years","volume":"9","author":"Friedman","year":"1994","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.mce.2011.05.044_b0580","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.1210\/jc.86.11.5593","article-title":"Up-regulation by IGF-I of proliferating cell nuclear antigen and Bcl-2 protein expression in human uterine leiomyoma cells","volume":"86","author":"Gao","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2011.05.044_b0570","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1093\/oxfordjournals.humrep.a137937","article-title":"Insulin-like growth factor (IGF), IGF binding protein (IGFBP), and IGF receptor gene expression and IGFBP synthesis in human uterine leiomyomata","volume":"8","author":"Giudice","year":"1993","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.mce.2011.05.044_b0145","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/S0015-0282(03)00175-4","article-title":"Use of a levonorgestrel-releasing intrauterine system to treat bleeding related to uterine leiomyomas","volume":"79","author":"Grigorieva","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.mce.2011.05.044_b0110","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jmig.2006.04.003","article-title":"Volume change of uterine myomas during pregnancy: do myomas really grow?","volume":"13","author":"Hammoud","year":"2006","journal-title":"J. Minim. Invasive Gynecol."},{"key":"10.1016\/j.mce.2011.05.044_b0550","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1210\/jc.78.5.1179","article-title":"Quantification of messenger ribonucleic acid for epidermal growth factor in human myometrium and leiomyomata using reverse transcriptase polymerase chain reaction","volume":"78","author":"Harrison-Woolrych","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2011.05.044_b0345","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1210\/jc.2007-0823","article-title":"Adenovirus-mediated delivery of a dominant-negative estrogen receptor gene in uterine leiomyoma cells abrogates estrogen- and progesterone-regulated gene expression","volume":"92","author":"Hassan","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2011.05.044_b0725","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.fertnstert.2008.09.086","article-title":"Gene therapy targeting leiomyoma: adenovirus-mediated delivery of dominant-negative estrogen receptor gene shrinks uterine tumors in Eker rat model","volume":"93","author":"Hassan","year":"2010","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.mce.2011.05.044_b0400","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00428-008-0679-5","article-title":"Estrogen receptor alpha (ERalpha) phospho-serine-118 is highly expressed in human uterine leiomyomas compared to matched myometrium","volume":"453","author":"Hermon","year":"2008","journal-title":"Virchows Arch."},{"key":"10.1016\/j.mce.2011.05.044_b0370","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.fertnstert.2007.11.006","article-title":"Action of aromatase inhibitor for treatment of uterine leiomyoma in perimenopausal patients","volume":"91","author":"Hilario","year":"2009","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.mce.2011.05.044_b0340","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0303-7207(02)00230-7","article-title":"Transdominant suppression of estrogen receptor signaling by progesterone receptor ligands in uterine leiomyoma cells","volume":"196","author":"Hodges","year":"2002","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2011.05.044_b0735","doi-asserted-by":"crossref","unstructured":"Hoekstra, A.V., Sefton, E.C., Berry, E., Lu, Z., Hardt, J., Marsh, E., Yin, P., Clardy, J., Chakravarti, D., Bulun, S., Kim, J.J., 2009. Progestins activate the AKT pathway in leiomyoma cells and promote survival. J. Clin. Endocrinol. Metab. submitted for publication.","DOI":"10.1210\/mend.23.4.9996"},{"key":"10.1016\/j.mce.2011.05.044_b0295","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/humupd\/dmm023","article-title":"Progesterone receptor modulators and the endometrium: changes and consequences","volume":"13","author":"Horne","year":"2007","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.mce.2011.05.044_b0700","first-page":"1568","article-title":"Rodent model of reproductive tract leiomyomata. Establishment and characterization of tumor-derived cell lines","volume":"146","author":"Howe","year":"1995","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.mce.2011.05.044_b0605","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.fertnstert.2007.02.031","article-title":"Increased expression of platelet-derived growth factor C messenger ribonucleic acid in uterine leiomyomata","volume":"89","author":"Hwu","year":"2008","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.mce.2011.05.044_b0355","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1210\/jc.2006-2482","article-title":"Aromatase expression in uterine leiomyomata is regulated primarily by proximal promoters I.3\/II","volume":"92","author":"Imir","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2011.05.044_b0360","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1210\/jc.2008-2327","article-title":"High aromatase expression in uterine leiomyoma tissues of African-American women","volume":"94","author":"Ishikawa","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2011.05.044_b0350","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1210\/en.2009-1225","article-title":"Progesterone is essential for maintenance and growth of uterine leiomyoma","volume":"151","author":"Ishikawa","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2011.05.044_b0160","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1093\/humrep\/13.12.3379","article-title":"The effect of a levonorgestrel-releasing intrauterine system on uterine artery blood flow, hormone concentrations and ovarian cyst formation in fertile women","volume":"13","author":"Jarvela","year":"1998","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.mce.2011.05.044_b0445","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1016\/j.fertnstert.2009.03.100","article-title":"Changes related to phosphatidylinositol 3-kinase\/Akt signaling in leiomyomas: possible involvement of glycogen synthase kinase 3alpha and cyclin D2 in the pathophysiology","volume":"93","author":"Karra","year":"2010","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.mce.2011.05.044_b0090","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0002-9378(89)80046-8","article-title":"Mitotic activity in uterine leiomyomas during the menstrual cycle","volume":"160","author":"Kawaguchi","year":"1989","journal-title":"Am. J. Obstet. Gynaecol."},{"key":"10.1016\/j.mce.2011.05.044_b0085","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF01606522","article-title":"Immunohistochemical analysis of oestrogen receptors, progesterone receptors and Ki-67 in leiomyoma and myometrium during the menstrual cycle and pregnancy","volume":"419","author":"Kawaguchi","year":"1991","journal-title":"Virchows Arch. A Pathol. Anat. Histopathol."},{"key":"10.1016\/j.mce.2011.05.044_b0610","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1177\/1933719107305866","article-title":"Expression of proliferative and preapoptotic molecules in human myometrium and leiomyoma throughout the menstrual cycle","volume":"14","author":"Kayisli","year":"2007","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.mce.2011.05.044_b0020","first-page":"483","article-title":"Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis","volume":"41","author":"Kjerulff","year":"1996","journal-title":"J. Reprod. Med."},{"key":"10.1016\/j.mce.2011.05.044_b0675","doi-asserted-by":"crossref","unstructured":"Klemke, M., Meyer, A., Hashemi Nezhad, M., Belge, G., Bartnitzke, S., Bullerdiek, J., 2010. Loss of let-7 binding sites resulting from truncations of the 3\u2019 untranslated region of HMGA2 mRNA in uterine leiomyomas. Cancer Genet Cytogenet 196, 119\u201323.","DOI":"10.1016\/j.cancergencyto.2009.09.021"},{"key":"10.1016\/j.mce.2011.05.044_b0705","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/ng0195-70","article-title":"A germline insertion in the tuberous sclerosis (Tsc2) gene gives rise to the Eker rat model of dominantly inherited cancer","volume":"9","author":"Kobayashi","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mce.2011.05.044_b0435","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jsbmb.2003.09.007","article-title":"Differential expression of Akt\/protein kinase B, Bcl-2 and Bax proteins in human leiomyoma and myometrium","volume":"87","author":"Kovacs","year":"2003","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2011.05.044_b0450","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jsbmb.2006.08.006","article-title":"Phosphorylation of PTEN (phosphatase and tensin homologue deleted on chromosome ten) protein is enhanced in human fibromyomatous uteri","volume":"103","author":"Kovacs","year":"2007","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2011.05.044_b0440","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.fertnstert.2009.07.1670","article-title":"Involvement of FKHR (FOXO1) transcription factor in human uterus leiomyoma growth","volume":"94","author":"Kovacs","year":"2010","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.mce.2011.05.044_b0710","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/j.1349-7006.1995.tb03092.x","article-title":"Allelic loss at the tuberous sclerosis (Tsc2) gene locus in spontaneous uterine leiomyosarcomas and pituitary adenomas in the Eker rat model","volume":"86","author":"Kubo","year":"1995","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/j.mce.2011.05.044_b0120","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000292738","article-title":"Proliferative activity of human uterine leiomyoma cells as measured by automatic image analysis","volume":"34","author":"Lamminen","year":"1992","journal-title":"Gynecol. Obstet. Invest."},{"key":"10.1016\/j.mce.2011.05.044_b0475","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jsbmb.2007.09.019","article-title":"Integration of progesterone receptor action with rapid signaling events in breast cancer models","volume":"108","author":"Lange","year":"2008","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2011.05.044_b0540","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1210\/jc.86.2.913","article-title":"Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-beta 3 (TGF beta 3) and altered responses to the antiproliferative effects of TGF beta","volume":"86","author":"Lee","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2011.05.044_b0420","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.steroids.2007.03.001","article-title":"Effect of estrogen and inhibition of phosphatidylinositol-3 kinase on Akt and FOXO1 in rat uterus","volume":"72","author":"Lengyel","year":"2007","journal-title":"Steroids"},{"key":"10.1016\/j.mce.2011.05.044_b0275","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/AOG.0b013e3181705d0e","article-title":"CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial","volume":"111","author":"Levens","year":"2008","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.mce.2011.05.044_b0590","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4161\/cbt.5.1.2234","article-title":"Expression and functional analysis of platelet-derived growth factor in uterine leiomyomata","volume":"5","author":"Liang","year":"2006","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.mce.2011.05.044_b0685","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1055\/s-0028-1096130","article-title":"The expression and potential regulatory function of microRNAs in the pathogenesis of leiomyoma","volume":"26","author":"Luo","year":"2008","journal-title":"Semin. Reprod. Med."},{"key":"10.1016\/j.mce.2011.05.044_b0660","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.1210\/jc.2009-1286","article-title":"Progesterone and mifepristone regulate L-type amino acid transporter 2 and 4F2 heavy chain expression in uterine leiomyoma cells","volume":"94","author":"Luo","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2011.05.044_b0640","doi-asserted-by":"crossref","unstructured":"Luo, X., Yin, P., Coon, V.J., Cheng, Y.H., Wiehle, R.D., Bulun, S.E., 2010. The selective progesterone receptor modulator CDB4124 inhibits proliferation and induces apoptosis in uterine leiomyoma cells. Fertil. Steril. 93, 2668\u201373.","DOI":"10.1016\/j.fertnstert.2009.11.031"},{"key":"10.1016\/j.mce.2011.05.044_b0075","first-page":"200","article-title":"Myomectomy: recurrence after removal of solitary and multiple myomas","volume":"34","author":"Malone","year":"1969","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.mce.2011.05.044_b0320","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0092-8674(95)90199-X","article-title":"The nuclear receptor superfamily: the second decade","volume":"83","author":"Mangelsdorf","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.mce.2011.05.044_b0600","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1095\/biolreprod53.3.636","article-title":"Isolation and characterization of heparin-binding growth factors in human leiomyomas and normal myometrium","volume":"53","author":"Mangrulkar","year":"1995","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.mce.2011.05.044_b0330","first-page":"19","article-title":"Estrogen and progesterone receptors in leiomyomas and normal uterine tissues during reproductive life","volume":"20","author":"Marelli","year":"1989","journal-title":"Acta Eur. Fertil."},{"key":"10.1016\/j.mce.2011.05.044_b0695","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/j.fertnstert.2007.05.074","article-title":"Differential expression of microRNA species in human uterine leiomyoma versus normal myometrium","volume":"89","author":"Marsh","year":"2008","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.mce.2011.05.044_b0635","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0039-128X(00)00171-9","article-title":"Effects of progesterone on uterine leiomyoma growth and apoptosis","volume":"65","author":"Maruo","year":"2000","journal-title":"Steroids"},{"key":"10.1016\/j.mce.2011.05.044_b0270","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1016\/j.contraception.2007.01.025","article-title":"Effects of levonorgestrel-releasing IUS and progesterone receptor modulator PRM CDB-2914 on uterine leiomyomas","volume":"75","author":"Maruo","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.mce.2011.05.044_b0645","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1210\/jc.82.1.293","article-title":"Increased expression of Bcl-2 protein in human uterine leiomyoma and its up-regulation by progesterone","volume":"82","author":"Matsuo","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2011.05.044_b0115","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0002-9378(16)36139-7","article-title":"Response of fibromyomas to a progestin","volume":"82","author":"Mixson","year":"1961","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.mce.2011.05.044_b0230","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/humrep\/den025","article-title":"Selective progesterone receptor modulator asoprisnil down-regulates collagen synthesis in cultured human uterine leiomyoma cells through up-regulating extracellular matrix metalloproteinase inducer","volume":"23","author":"Morikawa","year":"2008","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.mce.2011.05.044_b0195","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1210\/jc.76.2.513","article-title":"Regression of uterine leiomyomata in response to the antiprogesterone RU 486","volume":"76","author":"Murphy","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2011.05.044_b0200","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0015-0282(16)57678-X","article-title":"Regression of uterine leiomyomata to the antiprogesterone RU486: dose-response effect","volume":"64","author":"Murphy","year":"1995","journal-title":"Fertil Steril"},{"key":"10.1016\/j.mce.2011.05.044_b0290","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/modpathol.2008.19","article-title":"The spectrum of endometrial pathology induced by progesterone receptor modulators","volume":"21","author":"Mutter","year":"2008","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.mce.2011.05.044_b0035","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1017\/S0007114508083566","article-title":"Association of intakes of fat, dietary fibre, soya isoflavones and alcohol with uterine fibroids in Japanese women","volume":"101","author":"Nagata","year":"2009","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.mce.2011.05.044_b0310","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1210\/jc.2003-031945","article-title":"Low-dose mifepristone inhibits endometrial proliferation and up-regulates androgen receptor","volume":"89","author":"Narvekar","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2011.05.044_b0105","first-page":"671","article-title":"Pregnancy-related changes in the size of uterine leiomyomas","volume":"51","author":"Neiger","year":"2006","journal-title":"J. Reprod. Med."},{"key":"10.1016\/j.mce.2011.05.044_b0395","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1210\/en.2008-0224","article-title":"Human uterine smooth muscle and leiomyoma cells differ in their rapid 17beta-estradiol signaling: implications for proliferation","volume":"150","author":"Nierth-Simpson","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2011.05.044_b0505","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1177\/1933719109343310","article-title":"Transforming growth factor beta3 regulates the versican variants in the extracellular matrix-rich uterine leiomyomas","volume":"16","author":"Norian","year":"2009","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.mce.2011.05.044_b0235","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/1933719107311464","article-title":"Comparative effects of SPRM asoprisnil (J867) on proliferation, apoptosis, and the expression of growth factors in cultured uterine leiomyoma cells and normal myometrial cells","volume":"14","author":"Ohara","year":"2007","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.mce.2011.05.044_b0155","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.3109\/00016349.2010.512068","article-title":"Down-regulated progesterone receptor A and B coinciding with successful treatment of endometrial hyperplasia by the levonorgestrel impregnated intrauterine system","volume":"89","author":"Orbo","year":"2010","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.mce.2011.05.044_b0690","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1582-4934.2007.00207.x","article-title":"Differential expression of microRNAs in myometrium and leiomyomas and regulation by ovarian steroids","volume":"12","author":"Pan","year":"2008","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.mce.2011.05.044_b0670","doi-asserted-by":"crossref","unstructured":"Pan, Q., Luo, X., Chegini, N., 2010. microRNA 21: response to hormonal therapies and regulatory function in leiomyoma, transformed leiomyoma and leiomyosarcoma cells. Mol Hum Reprod 16, 215\u201327.","DOI":"10.1093\/molehr\/gap093"},{"key":"10.1016\/j.mce.2011.05.044_b0375","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.fertnstert.2008.09.064","article-title":"A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status","volume":"93","author":"Parsanezhad","year":"2009","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.mce.2011.05.044_b0015","doi-asserted-by":"crossref","first-page":"19887","DOI":"10.1073\/pnas.0808188105","article-title":"Growth of uterine leiomyomata among premenopausal black and white women","volume":"105","author":"Peddada","year":"2008","journal-title":"Proc. Nat. Acad. Sci. USA"},{"key":"10.1016\/j.mce.2011.05.044_b0510","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1016\/j.fertnstert.2007.10.083","article-title":"Expression of insulin-like growth factors (IGFs) and IGF signaling: molecular complexity in uterine leiomyomas","volume":"91","author":"Peng","year":"2009","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.mce.2011.05.044_b0205","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0002-9378(94)70332-9","article-title":"The effects of RU 486 and leuprolide acetate on uterine artery blood flow in the fibroid uterus: a prospective, randomized study","volume":"170","author":"Reinsch","year":"1994","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.mce.2011.05.044_b0325","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1242\/jcs.00247","article-title":"The nuclear receptor superfamily","volume":"116","author":"Robinson-Rechavi","year":"2003","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.mce.2011.05.044_b0095","doi-asserted-by":"crossref","first-page":"511","DOI":"10.7863\/jum.1992.11.10.511","article-title":"Longitudinal evaluation of uterine myoma growth during pregnancy. A sonographic study","volume":"11","author":"Rosati","year":"1992","journal-title":"J. Ultrasound Med."},{"key":"10.1016\/j.mce.2011.05.044_b0025","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1136\/bmj.293.6543.359","article-title":"Risk factors for uterine fibroids: reduced risk associated with oral contraceptives","volume":"293","author":"Ross","year":"1986","journal-title":"Br. Med. J. (Clin Res Ed)"},{"issue":"Pt 3","key":"10.1016\/j.mce.2011.05.044_b0335","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/000456328702400304","article-title":"Oestrogen and progesterone receptor concentrations in leiomyoma and normal myometrium","volume":"24","author":"Sadan","year":"1987","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.mce.2011.05.044_b0385","doi-asserted-by":"crossref","first-page":"e7356","DOI":"10.1371\/journal.pone.0007356","article-title":"Catechol-o-methyltransferase expression and 2-methoxyestradiol affect microtubule dynamics and modify steroid receptor signaling in leiomyoma cells","volume":"4","author":"Salama","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.mce.2011.05.044_b0240","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1210\/jc.2006-0898","volume":"92","author":"Sasaki","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2011.05.044_b0040","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijgo.2010.08.009","article-title":"A randomized clinical trial of a levonorgestrel-releasing intrauterine system and a low-dose combined oral contraceptive for fibroid-related menorrhagia","volume":"112","author":"Sayed","year":"2011","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.mce.2011.05.044_b0495","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0092-8674(00)00114-8","article-title":"Cell signaling by receptor tyrosine kinases","volume":"103","author":"Schlessinger","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.mce.2011.05.044_b0555","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1210\/jc.83.6.2192","article-title":"Up-regulation by progesterone of proliferating cell nuclear antigen and epidermal growth factor expression in human uterine leiomyoma","volume":"83","author":"Shimomura","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2011.05.044_b0365","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1055\/s-2004-823027","article-title":"Aromatase and leiomyoma of the uterus","volume":"22","author":"Shozu","year":"2004","journal-title":"Semin. Reprod. Med."},{"key":"10.1016\/j.mce.2011.05.044_b0545","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1093\/humrep\/deh355","article-title":"The AG1478 tyrosine kinase inhibitor is an effective suppressor of leiomyoma cell growth","volume":"19","author":"Shushan","year":"2004","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.mce.2011.05.044_b0045","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000080932","article-title":"The efficacy of levonorgestrel-releasing intrauterine device in selected cases of myoma-related menorrhagia: a prospective controlled trial","volume":"59","author":"Soysal","year":"2005","journal-title":"Gynecol. Obstet. Invest."},{"key":"10.1016\/j.mce.2011.05.044_b0280","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/GCO.0b013e32832e07e8","article-title":"Clinical utility of progesterone receptor modulators and their effect on the endometrium","volume":"21","author":"Spitz","year":"2009","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"10.1016\/j.mce.2011.05.044_b0050","first-page":"1221","article-title":"Intrauterine therapy with levonorgestrel releasing IUD of women with hypermenorrhea secondary to uterine fibroids","volume":"71","author":"Starczewski","year":"2000","journal-title":"Ginekol. Pol."},{"key":"10.1016\/j.mce.2011.05.044_b0315","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/j.fertnstert.2008.12.057","article-title":"Endometrial effects of a single early luteal dose of the selective progesterone receptor modulator CDB-2914","volume":"93","author":"Stratton","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.mce.2011.05.044_b0585","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/0002-9378(95)91420-X","article-title":"Insulin-like growth factor I promotes leiomyoma cell growth in vitro","volume":"172","author":"Strawn","year":"1995","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.mce.2011.05.044_b0535","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1095\/biolreprod.109.076869","article-title":"Platelet-derived growth factor C is upregulated in human uterine fibroids and regulates uterine smooth muscle cell growth","volume":"81","author":"Suo","year":"2009","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.mce.2011.05.044_b0620","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/molehr\/3.3.233","article-title":"The expression of transforming growth factor-beta s and TGF-beta receptor mRNA and protein and the effect of TGF-beta s on human myometrial smooth muscle cells in vitro","volume":"3","author":"Tang","year":"1997","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.mce.2011.05.044_b0150","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00404-008-0871-5","article-title":"Treatment of menorrhagia with the levonorgestrel releasing intrauterine system: effects on ovarian function and uterus","volume":"280","author":"Tasci","year":"2009","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.mce.2011.05.044_b0730","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1620\/tjem.222.55","article-title":"Establishment of a novel xenograft model for human uterine leiomyoma in immunodeficient mice","volume":"222","author":"Tsuiji","year":"2010","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.mce.2011.05.044_b0425","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1210\/me.2005-0016","article-title":"Progestin activation of nongenomic pathways via cross talk of progesterone receptor with estrogen receptor beta induces proliferation of endometrial stromal cells","volume":"19","author":"Vallejo","year":"2005","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2011.05.044_b0515","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/ijc.2910590323","article-title":"Growth advantage of human leiomyoma cells compared to normal smooth-muscle cells due to enhanced sensitivity toward insulin-like growth factor I","volume":"59","author":"van der Ven","year":"1994","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.mce.2011.05.044_b0520","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1210\/jc.76.5.1106","article-title":"Messenger ribonucleic acid expression of the insulin-like growth factors and their binding proteins in uterine fibroids and myometrium","volume":"76","author":"Vollenhoven","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2011.05.044_b0560","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1093\/humrep\/del035","article-title":"A novel selective progesterone receptor modulator asoprisnil (J867) down-regulates the expression of EGF, IGF-I, TGFbeta3 and their receptors in cultured uterine leiomyoma cells","volume":"21","author":"Wang","year":"2006","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.mce.2011.05.044_b0680","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1055\/s-0028-1096131","article-title":"MicroRNA: a new tool for biomedical risk assessment and target identification in human uterine leiomyomas","volume":"26","author":"Wei","year":"2008","journal-title":"Semin. Reprod. Med."},{"key":"10.1016\/j.mce.2011.05.044_b0055","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0301-2115(01)00555-3","article-title":"The effect on menstrual blood loss in women with uterine fibroids of a novel \u201cframeless\u201d intrauterine levonorgestrel-releasing drug delivery system: a pilot study","volume":"102","author":"Wildemeersch","year":"2002","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.mce.2011.05.044_b0220","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.1210\/jc.2008-1104","article-title":"Effects of the selective progesterone receptor modulator asoprisnil on uterine artery blood flow, ovarian activity, and clinical symptoms in patients with uterine leiomyomata scheduled for hysterectomy","volume":"93","author":"Wilkens","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2011.05.044_b0245","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/humrep\/den494","article-title":"Effect of asoprisnil on uterine proliferation markers and endometrial expression of the tumour suppressor gene, PTEN","volume":"24","author":"Wilkens","year":"2009","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.mce.2011.05.044_b0285","doi-asserted-by":"crossref","unstructured":"Williams, A.R., Critchley, H.O., Osei, J., Ingamells, S., Cameron, I.T., Han, C., Chwalisz, K., 2007. The effects of the selective progesterone receptor modulator asoprisnil on the morphology of uterine tissues after 3 months treatment in patients with symptomatic uterine leiomyomata. Hum Reprod.","DOI":"10.1093\/humrep\/dem026"},{"key":"10.1016\/j.mce.2011.05.044_b0380","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/humrep\/deg059","article-title":"Influence of the catechol-O-methyltransferase (COMT) codon 158 polymorphism on estrogen levels in women","volume":"18","author":"Worda","year":"2003","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.mce.2011.05.044_b0265","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1210\/jc.2004-1569","article-title":"Progesterone receptor modulator CDB-2914 down-regulates proliferative cell nuclear antigen and Bcl-2 protein expression and up-regulates caspase-3 and poly(adenosine 5\u2019-diphosphate-ribose) polymerase expression in cultured human uterine leiomyoma cells","volume":"90","author":"Xu","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2011.05.044_b0255","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1093\/humrep\/del159","article-title":"Progesterone receptor modulator CDB-2914 down-regulates vascular endothelial growth factor, adrenomedullin and their receptors and modulates progesterone receptor content in cultured human uterine leiomyoma cells","volume":"21","author":"Xu","year":"2006","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.mce.2011.05.044_b0250","doi-asserted-by":"crossref","first-page":"E1002","DOI":"10.1152\/ajpendo.00210.2007","article-title":"Selective progesterone receptor modulator asoprisnil induces endoplasmic reticulum stress in cultured human uterine leiomyoma cells","volume":"293","author":"Xu","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2011.05.044_b0260","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/molehr\/gan004","article-title":"Progesterone receptor modulator CDB-2914 induces extracellular matrix metalloproteinase inducer in cultured human uterine leiomyoma cells","volume":"14","author":"Xu","year":"2008","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.mce.2011.05.044_b0165","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.contraception.2010.03.002","article-title":"Levonorgestrel inhibits proliferation and induces apoptosis in uterine leiomyoma cells","volume":"82","author":"Xu","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.mce.2011.05.044_b0565","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/humrep\/deh146","article-title":"Progesterone down-regulates insulin-like growth factor-I expression in cultured human uterine leiomyoma cells","volume":"19","author":"Yamada","year":"2004","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.mce.2011.05.044_b0650","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1210\/jc.2007-0725","article-title":"Progesterone receptor regulates Bcl-2 gene expression through direct binding to its promoter region in uterine leiomyoma cells","volume":"92","author":"Yin","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2011.05.044_b0455","doi-asserted-by":"crossref","first-page":"176 e1-5","DOI":"10.1016\/j.ajog.2006.09.037","article-title":"Requirements of phosphatidylinositol-3 kinase and mammalian target of rapamycin for estrogen-induced proliferation in uterine leiomyoma- and myometrium-derived cell lines","volume":"196","author":"Yin","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.mce.2011.05.044_b0655","doi-asserted-by":"crossref","unstructured":"Yin, P., Lin, Z., Reierstad, S., Wu, J., Ishikawa, H., Marsh, E.E., Innes, J., Cheng, Y., Pearson, K., Coon, J.S.t., Kim, J.J., Chakravarti, D., Bulun, S.E., 2010. Transcription factor KLF11 integrates progesterone receptor signaling and proliferation in uterine leiomyoma cells. Cancer. Res. 70, 1722\u201330.","DOI":"10.1158\/0008-5472.CAN-09-2612"},{"key":"10.1016\/j.mce.2011.05.044_b0575","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1080\/09513590902972117","article-title":"Dual actions of progesterone on uterine leiomyoma correlate with the ratio of progesterone receptor A:B","volume":"25","author":"Ying","year":"2009","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.mce.2011.05.044_b0525","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2119\/2007-00101.Yu","article-title":"Differential expression of receptor tyrosine kinases (RTKs) and IGF-I pathway activation in human uterine leiomyomas","volume":"14","author":"Yu","year":"2008","journal-title":"Mol. Med."},{"key":"10.1016\/j.mce.2011.05.044_b0485","doi-asserted-by":"crossref","unstructured":"Yu, L., Moore, A.B., Dixon, D., 2010. Receptor tyrosine kinases and their hormonal regulation in uterine leiomyoma. Semin. Reprod. Med. 28, 180\u2013203.","DOI":"10.1055\/s-0030-1251482"},{"key":"10.1016\/j.mce.2011.05.044_b0665","doi-asserted-by":"crossref","unstructured":"Zavadil, J., Ye, H., Liu, Z., Wu, J., Lee, P., Hernando, E., Soteropoulos, P., Toruner, G.A., Wei, J.J., 2010. Profiling and functional analyses of microRNAs and their target gene products in human uterine leiomyomas. PLoS One 5, e12362.","DOI":"10.1371\/journal.pone.0012362"},{"key":"10.1016\/j.mce.2011.05.044_b0465","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1677\/ERC-08-0084","article-title":"Androgen receptor and growth factor signaling cross-talk in prostate cancer cells","volume":"15","author":"Zhu","year":"2008","journal-title":"Endocr. Relat. Cancer"}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720711002991?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720711002991?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T13:48:11Z","timestamp":1560260891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720711002991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":146,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0303720711002991"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2011.05.044","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}